PsoProtect is an international registry developed to enable clinicians to report outcomes of COVID-19 in individuals with psoriasis. It is hoped that PsoProtect will help us to understand how immunomodulator therapies and comorbidities impact outcomes to COVID-19 in psoriasis and it will provide real-time updates on cases reported for the benefit of the dermatology community. PsoProtect seeks to improve our understanding of how factors such as immunomodulator therapies and comorbidities impact outcomes to COVID-19 in psoriasis.
IPC is pleased to be part of this important initiative and asks if you have a psoriasis patient diagnosed with COVID-19, please contribute to this important registry by submitting your case using the online PsoProtect case report form.
In addition, an adjoining registry PsoProtectMe has been set up for patients to self-report their experiences.
View the current data. You can also view our summary of the data collected from the first 50 cases, 200 cases, or 1002 cases.
WATCH NOW Catherine Smith, MD, and Savteer Mahil, MD, talk to IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD, about their goals for the PsoProtect patient registry to study COVID-19 and psoriasis.
Latest news INSIDE LOOK campaign raises awareness about plaque psoriasisJune 16, 2021Amgen and Otezla® (apremilast) have partnered with Allan Avendaño, makeup artist to Hollywood A-listers, for the INSIDE LOOK campaign to share his journey living with plaque psoriasis and the difficulties of being in his demanding role and dealing with a chronic skin condition. Dermavant submits New Drug Application to FDA for tapinarof cream for the treatment plaque psoriasisJune 09, 2021Dermavant Sciences announced on June 3, 2021 that it has submitted a New Drug Application to the U.S. Food and Drug Administration for tapinarof for the treatment of mild, moderate and severe plaque psoriasis in adult patients. IPC International Fellow wins first prize for 2021 RADLA Poster PresentationJune 09, 20212019 IPC Fellow Romina Contreras was recognized at the 2021 Virtual RADLA Congress, winning first prize for her poster presentation. New data from the PsoProtect RegistryJune 01, 2021Update on the PsoProtect Registry. PsoProtect is a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. Data set currently includes 1,118 cases. More News
